Comprehensive Interrogation of the Genetic Determinants of Female and Male Infertility: A New NGS Research Application Enabled by Improvements in Target Enrichment Technology

How ICH E6(R2) has given clinical development organizations the perfect opportunity to improve quality and lower costs through adoption of RBM and Centralized Monitoring.

The 4th Annual European Statistical Forum is taking place on Monday, the 18th of November in Amsterdam, and CROS NT is going to play an important role in this year's conference as sponsor, chair and presenter.

CROS NT has officially expanded to the United Kingdom by establishing CROS NT Limited and opening office space in Atterbury Lakes Business Park in Milton Keynes.

HOUSTON, TX, Jun. 26, 2012 - Pharm-Olam International Ltd. (POI) a multi-national full service CRO to pharmaceutical and biotech industries, is pleased to welcome Josh Baker, Ph.D. as Vice President, Biostatistics.